Detalhe da pesquisa
1.
Distinct microbial and immune niches of the human colon.
Nat Immunol
; 21(3): 343-353, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066951
2.
Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases.
J Neuroinflammation
; 21(1): 32, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263227
3.
" I'm not a risk taker " : Risk Perceptions of Nursing Home Residents With Dementia.
Alzheimer Dis Assoc Disord
; 38(2): 168-177, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651790
4.
Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury.
J Immunol
; 207(1): 90-100, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145056
5.
Technical requirements and devices available for long-term hemodialysis in children-mind the gap!
Pediatr Nephrol
; 2023 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141144
6.
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data.
Mult Scler
; 28(5): 842-846, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882037
7.
Pain Incidence, Treatment, and Associated Symptoms in Hospitalized Persons with Dementia.
Pain Manag Nurs
; 22(2): 158-163, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32921569
8.
Function-Focused Goal Attainment and Discharge Outcomes in Hospitalized Persons With Dementia.
J Gerontol Nurs
; 47(9): 13-20, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34432570
9.
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease.
Brain Behav Immun
; 87: 473-488, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32006615
10.
Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab.
Mult Scler
; 26(9): 1093-1101, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31169059
11.
Extracellular Lactate: A Novel Measure of T Cell Proliferation.
J Immunol
; 200(3): 1220-1226, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288205
12.
Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.
Brain
; 141(3): 786-796, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361022
13.
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
JAMA
; 321(2): 175-187, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30644981
14.
Sarcoidosis following alemtuzumab treatment for multiple sclerosis.
Mult Scler
; 24(13): 1779-1782, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307364
15.
The yin and yang of intracellular reactive oxygen species following T-cell activation.
Brain
; 144(10): 2909-2911, 2021 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849600
16.
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
Proc Natl Acad Sci U S A
; 110(50): 20200-5, 2013 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24282306
17.
Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.
J Neurol Neurosurg Psychiatry
; 86(7): 708-13, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25246644
18.
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
J Neurol Neurosurg Psychiatry
; 86(2): 208-15, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24849515
19.
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 85(7): 795-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24368840
20.
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.
Brain
; 136(Pt 9): 2888-903, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23864273